AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
A new study adds to the wide body of research connecting chlorpyrifos to neurological effects, such as those experienced with Parkinson's.